David Keire
Advertisement
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles by David Keire
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Nuravax Alzheimer Vaccine AV-1959R Earns FDA Fast Track Designation
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
5